08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
In the UK, the definition of "worker" includes both employees and anyone else working under a contra...
Read More >
The Internal Revenue Service has announced the optional standard mileage rates for computing the ded...
Read More >
In 2019, OFCCP has been very busy increasing its enforcement activities and issuing policy changes. ...
Read More >
The UK Supreme Court has today published its long-awaited judgment in Egon Zehnder Ltd v Tillman. It...
Read More >
After weeks of Updates detailing the disastrous effects of COVID-19 on the lodging industry, this we...
Read More >
Main contractors often make claims against subcontractors for liquidated damages for delay. A questi...
Read More >